Impact Factor
3.72
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.05
776 total citations
h5-index
33
h5 depth signal
Cited share
79.8%
162 of 203
Total citations
776
Citation footprint
Metric signal
4.28
External metric anchor
Self-citation
5.7%
44 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
716
United States
342
Japan
128
South Korea
71
United Kingdom
47
Citing Fields of Research
Stem Cell Biology
728
Diabetes
152
Noncoding RNA
128
Immunology
125
Transplantation
116
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
5,147
Articles tracked across the journal lifetime
Indexed publication set
203
162 cited publications
Last 12 months
122
10.2 publications/month
Open access share
100.0%
122 OA publications in the last year
Leading citing country
China
716 citing publications
Leading citing field
Stem Cell Biology
728 citing publications
Latest tracked publication
18 October 2026
10 recent records available
Coverage & Indexing History
v1n1, 1992-
v1n1, 1992-
Active Coverage
Active Coverage
Research Focus & Classification
Indexed Subjects
Stem Cell Biology
Diabetes
Hematology
Transplantation
Immunology
Broad Categories
Cell Biology
Transplantation
Stem Cell Biology
Diabetes
Noncoding RNA
Hematology
Immunology
MeSH Descriptors
Cell Transplantation
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1177/09636897261499610
Open DOI
Personalized allogeneic hematopoietic stem cell transplantation in myelodysplastic syndromes: Integrating molecular risk, donor selection, and post-transplant strategies
Allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains the only treatment with curative potential for myelodysplastic syndromes (MDS). This review synthesizes MDS-specific evidence on transplant indication and timing, con...
02
DOI 10.1177/09636897261494929
Open DOI
Intranasal human neural stem cell therapy in early-onset Parkinson’s disease with motor complications: A randomized, double-blind, placebo-controlled trial
Background: To evaluate the safety and efficacy of intranasal transplantation of ANGE-S003 human neural stem cells (hNSCs) in early-onset Parkinson’s disease (EOPD) patients with motor complications. Methods: In this randomized, double-b...
03
DOI 10.1177/09636897261495824
Open DOI
Recent advances in the discovery, characterization, and therapeutic efficacy of antler stem cells and their secreted extracellular vesicles
Deer antlers are the only mammalian appendage capable of complete regeneration, with antler stem cells (AnSCs) playing a central role in this process. Extracellular vesicles (EVs) secreted by AnSCs function as the key paracrine mediators...
04
DOI 10.1177/09636897251414002
Open DOI
Potential therapeutics ingredients for dental pulp regeneration focusing on DPSCs and DPSC secretome with market projection
Regeneration of dental pulp has surfaced as an exciting area of exploration in regenerative endodontics, as a result of progress in stem cell biology and their applications, along with biomaterials. Of the different cell populations stud...
05
DOI 10.1177/09636897261493864
Open DOI
Machine learning models using longitudinal laboratory data predict survival in allogeneic stem cell recipients
Allogeneic hematopoietic stem cell transplantation (HSCT) remains a potentially curative therapy for hematologic malignancies and bone marrow failure syndromes, yet outcomes remain highly heterogeneous and existing prognostic tools rely ...
06
DOI 10.1177/09636897261492438
Open DOI
A pilot phase IIa randomized, placebo-controlled, double-blind trial of intravenous human pluripotent adipose-derived stem cells (PASCs) in Parkinson’s disease: The REPOSE study
Pluripotent adipose-derived stem cells (PASCs) are a non-tumorigenic, stress-enduring SSEA-3 + cell population sharing key biological markers with Muse cells while representing a phenotypically distinct population. This Phase IIa randomi...
07
DOI 10.1177/09636897261486247
Open DOI
Management of donor-specific antibodies in allogeneic hematopoietic cell transplantation: A retrospective single-center case-control study
Donor-specific antibodies (DSA) are preformed recipient antibodies directed against donor HLA antigens, most frequently observed in haploidentical or mismatched allogeneic hematopoietic cell transplantation (HCT). DSA assessed by multipl...
08
DOI 10.1177/09636897261487114
Open DOI
The CNTN1/Gilz pathway mediates the therapeutic effect of mesenchymal stem cells on Echinococcus multilocularis -induced hepatic inflammation and fibrosis
Mesenchymal stem cells (MSCs) exhibit potent immunomodulatory properties, yet their precise mechanisms in alleviating Echinococcus multilocularis-induced hepatic inflammation and fibrosis in Alveolar Echinococcosis (AE) remain elusive. T...
09
DOI 10.1177/09636897261486242
Open DOI
Stem cell strategies for cell replacement therapy in endocrine diseases
Conventional therapies for endocrine hormone deficiencies, including hormone replacement therapy and solid organ transplantation, are hampered by the lack of physiological regulation or donor shortage, respectively. Directed differentiat...
10
DOI 10.1177/09636897261495817
Open DOI
Long-term survival of autologous peripheral nerve fascicles transplanted into the substantia nigra of participants with Parkinson disease: Preliminary observations
Cell transplantation therapies for Parkinson disease (PD) require confirmation that grafted tissue withstands the degenerative environment of the diseased brain. Autologous peripheral nerve tissue (PNT) grafts transplanted into the subst...
Bibliographical & Catalog Notes
Place of publication varies.
Also available online.
Vol. 4, no. 2 (MAR-APR 1995)19950519 Notice not published Printed on acid-free paper